February 27, 2019 · STOCK Act disclosure
Representative Mike Kelly (Republican-PA) bought Alexion Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on February 27, 2019 and was disclosed on March 14, 2019 (owner: Spouse). Members of Congress must report such transactions within 45 days under the STOCK Act.